Cargando…

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

OBJECTIVES: Response to immune checkpoint inhibitor (ICI) remains limited to a subset of patients and predictive biomarkers of response remains an unmet need, limiting our ability to provide precision medicine. Using real-world data, we aimed to identify potential clinical prognosticators of ICI res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Qian, Jun, Tomi, Wang, Bo, Patel, Vaibhav G., Mellgard, George, Zhong, Xiaobo, Gogerly-Moragoda, Mahalya, Parikh, Anish B., Leiter, Amanda, Gallagher, Emily J., Alerasool, Parissa, Garcia, Philip, Joshi, Himanshu, MBBS, Galsky, Matthew, Oh, William K., Tsao, Che-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374856/ https://www.ncbi.nlm.nih.gov/pubmed/35960456 http://dx.doi.org/10.1007/s12672-022-00538-6

Ejemplares similares

THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System
por: Gogerly-Moragoda, Mahalya, et al.
Publicado: (2023)

The COVID-19 pandemic and its impact on health experiences of asylum seekers to the United States
por: Singer, Elizabeth, et al.
Publicado: (2023)

SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy
por: Thapi, Sahityasri, et al.
Publicado: (2019)

Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
por: Thapi, Sahityasri, et al.
Publicado: (2019)

PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)

Detection of Cell Surface Ligands for Human Synovial γδ T Cells
por: Collins, Cheryl, et al.
Publicado: (2019)

MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors
por: Brooks, Danielle, et al.
Publicado: (2019)

SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019)

SAT-411 Vitamin D Levels and Risk of Thyroid Immune Related Adverse Events in Patients on Immune Checkpoint Inhibitors
por: Newman, Samantha Kass, et al.
Publicado: (2020)

Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
por: Sindhu, Kunal K., et al.
Publicado: (2022)

Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Liaw, Bobby C, et al.
Publicado: (2022)

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
por: Galsky, Matthew D., et al.
Publicado: (2023)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023)

Immune Checkpoints in Solid Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2023)

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Understanding the study habits of Saudi residents in a psychiatry programme
por: Alkhamees MBBS, Abdulmajeed A.
Publicado: (2020)

Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real‐World Practice
por: Parikh, Ravi B., et al.
Publicado: (2019)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
por: Lin, Justin, et al.
Publicado: (2021)

Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies
por: Sivendran, Shanthi, et al.
Publicado: (2015)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican resident
por: Mellgard, George, et al.
Publicado: (2019)

[Cu(18)H(3)(S-Adm)(12)(PPh(3))(4)Cl(2)]: fusion of Platonic and Johnson solids through a Cu(0) center and its photophysical properties
por: Das, Anish Kumar, et al.
Publicado: (2022)

Role of Chemoports in Children with Hematological/Solid Tumor Malignancies - Technical Implications and Complications: An Institutional Experience
por: Redkar, Rajeev, et al.
Publicado: (2019)

Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
por: Peyraud, Florent, et al.
Publicado: (2020)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Infectious complications of immune checkpoint inhibitors in solid organ malignancies
por: Ross, Justine Abella, et al.
Publicado: (2021)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

Increasing cure rates of solid tumors by immune checkpoint inhibitors
por: Ma, Weijie, et al.
Publicado: (2023)

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
por: Shah, Neil J, et al.
Publicado: (2022)

Fragile X Syndrome in a Female With Homozygous Full-Mutation Alleles of the FMR1 Gene
por: Vafaeie, Farzane, et al.
Publicado: (2021)

Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
por: Tsao, Shiu Ying
Publicado: (2022)

Organizational Culture and Effective Leadership in Academic Medical Institutions
por: Bhardwaj, Anish
Publicado: (2022)

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
por: Kapoor, Akhil, et al.
Publicado: (2020)

Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2016)

Tetra-Primer ARMS PCR Optimization for Detection of IVS-II-I (G-A) and FSC 8/9 InsG Mutations in β-Thalassemia Major Patients in Isfahan Population
por: HAJIHOSEINI, Samaneh, et al.
Publicado: (2015)

The role of color Doppler in assisted reproduction: A narrative review
por: Sharma, Nidhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eu3v09shbhkg8hal4qpbj676ig